AbbVie (ABBV) was granted FDA orphan designation for an antibody drug conjugate comprising monoclonal antibody anti-SEZ6 IgG1 antibody conjugated to a Top1 inhibitor as a treatment of small cell lung cancer, according to a post to the FDA website.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV: